Tag archive for ‘Andexxa sequential sales drop in 4Q’
Portola: My Investment Thinking After the Sharp Price Drop (PTLA, Buy, $14.85)
Full Year Sales of Andexxa were Impressive but there was a Troubling Drop in Sequential Sales in US in 4Q, 2019 Portola held a conference call on January 9, 2020 to pre-announce disappointing 4Q sales for Andexxa in the US. Following its launch in May of 2019, Andexxa recorded US sales of $24 million in […]